Tag: Heart Failure
Dapagliflozin Beneficial for Heart Failure, Regardless of Frailty
Risk reduced for worsening heart failure or cardiovascular death, regardless of frailty index class
History of Female Infertility Tied to Risk for Heart Failure
Infertility associated with increased risk for heart failure with preserved ejection fraction, but not heart failure with reduced ejection fraction
SGLT2 Inhibitors Reduce Heart Failure Hospitalization
But no indication of protection against all-cause death, kidney disease progression, or kidney failure; increased risk of genital infection
Recommendations Updated for Management of Heart Failure
Sodium-glucose cotransporter-2 inhibitors recommended for HF with reduced, mildly reduced ejection fraction
ACC: Low-Sodium Intervention Has Little Benefit in Heart Failure
Low-sodium diet did not reduce composite primary outcome of cardiovascular admission to hospital or ED or all-cause death
Serum Sodium in Upper Part of Normal Range Linked to Heart Failure
Serum sodium above 143 mmol/L linked to increased odds of left ventricular hypertrophy, heart failure
FDA Expands Approval of Jardiance for Patients With Heart Failure
Jardiance received approval to reduce the risk for cardiovascular death and hospitalization for patients with heart failure
SGLT2is, SGLT2i/GLP-1RA May Prevent CV Events in T2DM
Current use of SGLT2is, GLP-1RAs, and their combination associated with significantly reduced risk of heart failure events
Atrial Shunt No Benefit for Heart Failure With Preserved EF
Subgroup analysis indicates treatment efficacy differed with presence or absence of pulmonary vascular disease unmasked by exercise
Risk for Heart Failure Cut With Faster Walking Speed
Older women who walk at an average or fast pace have lower risk for heart failure versus slower walkers
